77 results
8-K
EX-99.2
CRVO
CervoMed Inc
7 Feb 24
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
4:06pm
and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time
8-K
EX-99.1
CRVO
CervoMed Inc
5 Jan 24
CervoMed to Participate in the Emerging Growth Conference 66
4:05pm
and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time
8-K/A
EX-99.3
np5pqoyhlzoaxm
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.2
0ajecj7a44faz3d wwa4
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
9e6tk 55k
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
424B3
yx38fvz
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
fj2p0g3
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
gd28irnjn2
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
othpl2pmjm8daobe
3 Apr 23
Business combination disclosure
4:55pm
PRRN14A
26ok6 g6dot
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
DEFC14A
7go3 pcwlrc
5 Dec 22
Proxy in contested solicitation
5:12pm
PRRN14A
24ovh4y7
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm
PRER14A
mscgg4 yc18
28 Nov 22
Preliminary revised proxy
5:17pm
PREC14A
u70fkw 4aid
23 Nov 22
Preliminary proxy with contested solicitation
11:26am